EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    5.3.99.5 | Adenocarcinoma |
6393859 |
The effect of prostaglandin modulators on prostate tumor growth and metastasis. |
therapeutic application
unassigned |
4
0 |
| 5.3.99.5 | Adenocarcinoma |
8630277 |
Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC). |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 5.3.99.5 | Adenocarcinoma |
12630766 |
The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis. |
ongoing research
unassigned |
4
0 |
| 5.3.99.5 | Adenocarcinoma |
16357168 |
Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
1 |
| 5.3.99.5 | Adenocarcinoma of Lung |
24556579 |
Glycyrrhizin suppresses lung adenocarcinoma cell growth through inhibition of thromboxane synthase. |
causal interaction
therapeutic application
unassigned |
2
2
0 |
| 5.3.99.5 | Albuminuria |
30542084 |
Diverse associations between oxidative stress and thromboxane A2 in hypertensive glomerular injury. |
causal interaction
unassigned |
1
0 |
| 5.3.99.5 | Anaphylaxis |
2879917 |
N-(heterocyclic alkyl)pyrido[2,1-b]quinazoline-8-carboxamides as orally active antiallergy agents. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 5.3.99.5 | Aneurysm |
8781596 |
Systemic multiple aneurysms of the intracranial arteries and visceral arteries: case report. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 5.3.99.5 | Angina Pectoris |
2947145 |
[Treatment of angina pectoris. New perspectives] |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 5.3.99.5 | Angina Pectoris |
3941213 |
Selective thromboxane A2 synthetase inhibition in vasospastic angina pectoris. |
diagnostic usage
therapeutic application
unassigned |
3
2
0 |
